Contrast agent kinetics in the rabbit brain during exposure to therapeutic ultrasound.
Ultrasound-stimulated microbubbles are currently under investigation as a means of transiently disrupting the blood-brain barrier (BBB) and it has been shown that the strength of this effect is highly dependent on ultrasound exposure conditions. The objective of this study was to investigate the potential for contrast agent destruction in the brain under conditions relevant to BBB disruption with a view to determining its possible influence on effective exposure parameters. An ultrasound imaging array was mounted within the aperture of a 1.68-MHz focused therapy transducer. Pulse lengths of 10 ms were used at repetition rates of 0.1-2.0 Hz and pressures from 0.30-0.88 MPa. Contrast imaging was performed after the bolus injection of Definity, and contrast time-intensity curves were then analyzed for regions-of-interest exposed to the therapy beam. Individual therapy pulses resulted in microbubble destruction, with the degree of agent depletion and replenishment time increasing with transmit pressure. As the pulse repetition rate was increased, agent reperfusion between pulses was incomplete and the concentration within the beam was progressively diminished, to a degree dependent on both pressure and repetition rates. These results demonstrate that microbubble concentration can be substantially influenced by destruction induced by therapeutic ultrasound pulses. The kinetics of this effect may therefore be a significant factor influencing the efficiency of BBB disruption, suggesting that monitoring of the spatial and temporal distribution of contrast agents may be warranted to guide and optimize BBB disruption therapy in both preclinical and clinical contexts.
Goertz
David E
DE
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. goertz@sri.utoronto.ca
Wright
Cameron
C
Hynynen
Kullervo
K
D000818:Animals; D001812:Blood-Brain Barrier; D001921:Brain / Q000378:metabolism*; D003287:Contrast Media / Q000378:metabolism / Q000493:pharmacokinetics*; D007700:Kinetics; D023421:Models, Animal; D012372:ROC Curve; D011817:Rabbits; D013997:Time Factors; D014464:Ultrasonic Therapy
D003287:Contrast Media
Ultrasound Med Biol. 2003 Aug;29(8):1093-103
12946512
Biochem Biophys Res Commun. 2006 Feb 24;340(4):1085-90
16403441
Phys Med Biol. 2000 Apr;45(4):1071-83
10795992
J Acoust Soc Am. 1978 Aug;64(2):423-57
361793
Circulation. 2001 Nov 20;104(21):2582-7
11714654
J Acoust Soc Am. 1999 Apr;105(4):2519-27
10212433
IEEE Trans Ultrason Ferroelectr Freq Control. 2001 Jan;48(1):232-48
11367791
Invest Radiol. 2005 Mar;40(3):134-47
15714088
Phys Med Biol. 2006 Feb 21;51(4):793-807
16467579
Ultrasonics. 2008 Aug;48(4):279-96
18511095
Magn Reson Med. 2004 Jul;52(1):100-7
15236372
Ultrasound Med Biol. 2007 Jan;33(1):95-104
17189051
Ultrasound Med Biol. 2008 Jun;34(6):930-7
18294757
Circulation. 1998 Feb 10;97(5):473-83
9490243
Phys Med Biol. 2003 Oct 7;48(19):3225-37
14579862
Ultrasound Med Biol. 2008 May;34(5):834-40
18207311
Adv Drug Deliv Rev. 2008 Jun 30;60(10):1209-17
18486271
Int J Cancer. 2007 Aug 15;121(4):901-7
17437269
IEEE Trans Ultrason Ferroelectr Freq Control. 2006 Jun;53(6):1118-29
16846144
Radiology. 2001 Sep;220(3):640-6
11526261
Ultrason Sonochem. 2008 Apr;15(4):636-643
17910929
Ultrasound Med Biol. 2005 Nov;31(11):1527-37
16286030
Ultrasound Med Biol. 2008 Jul;34(7):1093-104
18378064
Ultrasound Med Biol. 2007 Apr;33(4):584-90
17337109
Ultrasound Med Biol. 2009 Dec;35(12):2007-20
19822390
Phys Med Biol. 2003 Aug 21;48(16):2577-89
12974575